MCID: RTC005
MIFTS: 49

Reticulosarcoma

Categories: Rare diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Reticulosarcoma

MalaCards integrated aliases for Reticulosarcoma:

Name: Reticulosarcoma 12 15 73
Lymphoma, Large-Cell 76 53
Diffuse Large B-Cell Lymphoma 73
Lymphoma, Non-Hodgkin 44
Histiocytic Lymphoma 12
Large-Cell Lymphomas 12
Large Cell Lymphoma 53
Histiocytic Sarcoma 73
Lymphoma Large Cell 55

Classifications:



Summaries for Reticulosarcoma

MalaCards based summary : Reticulosarcoma, also known as lymphoma, large-cell, is related to intravascular large b-cell lymphoma and alk-positive anaplastic large cell lymphoma. An important gene associated with Reticulosarcoma is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are Allograft rejection and NF-kappaB Signaling. The drugs Adcetris and rituximab have been mentioned in the context of this disorder. Affiliated tissues include b cells, t cells and bone, and related phenotypes are endocrine/exocrine gland and hematopoietic system

Wikipedia : 76 Anaplastic large-cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma involving aberrant T cells or... more...

Related Diseases for Reticulosarcoma

Diseases related to Reticulosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 95)
# Related Disease Score Top Affiliating Genes
1 intravascular large b-cell lymphoma 32.9 B2M BCL6
2 alk-positive anaplastic large cell lymphoma 32.8 ALK CCND3 MUC1 NPM1
3 primary cutaneous anaplastic large cell lymphoma 31.9 ALK GZMB MUC1 NPM1 PTPRC TIA1
4 reticulum cell sarcoma 31.6 MUC1 PTPRC TNFRSF8
5 lymphosarcoma 31.3 BCL6 PTPRC
6 anaplastic large cell lymphoma 31.2 ALK CLU GZMB MUC1 NPM1 PAX5
7 lymphoma, non-hodgkin, familial 30.1 ALK B2M BCL6 CASP3 CCND3 GZMB
8 lymphoma 29.9 ALK BCL6 NPM1 PAX5 TNFRSF8
9 alk-negative anaplastic large cell lymphoma 12.5
10 lymphoma, large-cell, immunoblastic 12.3
11 primary mediastinal b-cell lymphoma 11.6
12 anaplastic small cell lymphoma 11.5
13 primary mediastinal large b-cell lymphoma 11.3
14 langerhans cell histiocytosis 11.0
15 breast lymphoma 10.8 ALK BCL6
16 heart lymphoma 10.8 BCL6 PTPRC
17 testicular lymphoma 10.8 BCL6 PTPRC
18 orbit lymphoma 10.8 GZMB TIA1
19 lichen sclerosus et atrophicus 10.7 GZMB TIA1
20 lymphomatoid granulomatosis 10.7 GZMB TIA1
21 viral esophagitis 10.7 GZMB TIA1
22 lymphocytic gastritis 10.7 GZMB TIA1
23 subcutaneous panniculitis-like t-cell lymphoma 10.7 GZMB TIA1
24 natural killer cell leukemia 10.7 GZMB TIA1
25 intraocular lymphoma 10.7 BCL6 PAX5
26 hepatosplenic t-cell lymphoma 10.7 GZMB TIA1
27 t-cell/histiocyte rich large b cell lymphoma 10.7 BCL6 TNFRSF8
28 conventional fibrosarcoma 10.6 PTPRC TNFRSF8
29 primary central nervous system lymphoma 10.6 BCL6 PAX5
30 choriocarcinoma of the testis 10.6 GZMB TIA1
31 adult lymphoma 10.6 ALK TNFRSF8
32 testicular infarct 10.6 PTPRC TNFRSF8
33 giardiasis 10.6 GZMB TIA1
34 malignant leydig cell tumor 10.6 PAX5 TNFRSF8
35 multicentric castleman disease 10.5 BCL6 PAX5
36 primary effusion lymphoma 10.5 BCL6 CASP3
37 histiocytic and dendritic cell cancer 10.5 CLU PTPRC
38 infiltrating lipoma 10.5 GZMB TIA1
39 nodular lymphocyte predominant hodgkin lymphoma 10.5 BCL6 PAX5 PTPRC
40 epidural neoplasm 10.4 BCL6 PTPRC TNFRSF8
41 diffuse large b-cell lymphoma 10.4 ALK BCL6 TNFRSF8
42 immune system organ benign neoplasm 10.4 PTPRC TNFRSF8
43 mediastinal malignant lymphoma 10.4 BCL6 PAX5 TNFRSF8
44 lymphoblastic lymphoma 10.3 BCL6 PTPRC TRB
45 thymus lipoma 10.3 PTPRC TNFRSF8
46 cutaneous t cell lymphoma 10.3 GZMB TIA1 TNFRSF8
47 necrotizing sialometaplasia 10.3 GZMB TIA1
48 lymphomatoid papulosis 10.2 ALK GZMB NPM1 TIA1
49 mature b-cell neoplasm 10.2 B2M BCL6 PTPRC
50 reticulohistiocytic granuloma 10.2 PTPRC TNFRSF8

Graphical network of the top 20 diseases related to Reticulosarcoma:



Diseases related to Reticulosarcoma

Symptoms & Phenotypes for Reticulosarcoma

MGI Mouse Phenotypes related to Reticulosarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.86 CASP3 CCND3 PTPRC ALK ANPEP TNFRSF8
2 hematopoietic system MP:0005397 9.85 CASP3 CCND3 NPM1 PAX5 PTPRC TIA1
3 immune system MP:0005387 9.7 CASP3 CCND3 CLU NPM1 PAX5 PTPRC
4 neoplasm MP:0002006 9.1 CCND3 NPM1 PAX5 PTPRC ALK B2M

Drugs & Therapeutics for Reticulosarcoma

FDA approved drugs:

# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Adcetris 18 49 BRENTUXIMAB VEDOTIN Seattle Genetics August 2011

Drugs for Reticulosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 508)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
2
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
3
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
6
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
7
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
8
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
9
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2068-78-2, 57-22-7 5978
10
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1959-05-2, 59-05-2 126941
11
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
12
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
13
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-18-0, 6055-19-2 2907
14
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
15
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
16
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
17
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
18
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
19
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
20
Crizotinib Approved Phase 4,Phase 2,Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
21
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 143 6006
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
23
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 31703
24
Pirarubicin Investigational Phase 4 72496-41-4
25 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
27
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 0
28 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
29 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
31 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
32 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
34 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
36 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
37 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
38 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
39 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
40 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
41 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Antibodies Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
45 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable
46 Antibodies, Monoclonal Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable
47 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
49 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
50 Prednisolone phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 916)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Active, not recruiting NCT01909934 Phase 4 brentuximab vedotin
5 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
6 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
7 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
8 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
9 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
10 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
11 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
12 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
13 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
14 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
15 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
16 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
17 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
18 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
19 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
20 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
21 Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R Unknown status NCT00322218 Phase 3 Zevalin Therapeutic Regimen
22 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
23 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
24 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
25 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
26 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
27 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
28 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
29 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
30 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
31 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
32 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
33 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
34 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
35 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
36 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
37 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
38 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
39 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
40 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
41 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
42 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
44 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
45 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
46 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
47 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
48 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
49 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin
50 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate

Search NIH Clinical Center for Reticulosarcoma

Cochrane evidence based reviews: lymphoma, non-hodgkin

Genetic Tests for Reticulosarcoma

Anatomical Context for Reticulosarcoma

MalaCards organs/tissues related to Reticulosarcoma:

41
B Cells, T Cells, Bone, Bone Marrow, Liver, Kidney, Myeloid

Publications for Reticulosarcoma

Articles related to Reticulosarcoma:

(show top 50) (show all 80)
# Title Authors Year
1
An interesting case report of pancytopenia in a HIV seropositive patient-Primary bone marrow non Hodgkin's lymphoma large cell type. ( 27728570 )
2016
2
Establishment of a Patient-Derived Xenograft of Canine Enteropathy-Associated T-Cell Lymphoma, Large Cell Type. ( 28011041 )
2016
3
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. ( 11426330 )
2001
4
Splenic involvement by blastic mantle cell lymphoma (large cell/anaplastic variant) mimicking splenic marginal zone lymphoma. ( 10589081 )
1999
5
In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin. ( 8943689 )
1996
6
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. ( 2189589 )
1990
7
[A rare case of manifestation of reticulosarcoma by development of multiple cerebral hemorrhages]. ( 1963966 )
1990
8
[Treatment results in localized forms of reticulosarcoma and Ewing's sarcoma in children]. ( 2662605 )
1989
9
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. ( 3315188 )
1987
10
Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. ( 3322541 )
1987
11
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. ( 3100032 )
1987
12
Primary reticulosarcoma of bone (non-Hodgkin's lymphoma). A study of 12 cases. ( 3503874 )
1987
13
Round-cell sarcomas of bone and their differential diagnosis (with particular emphasis on Ewing's sarcoma and reticulosarcoma). A study of 233 tumors with optical and electron microscopic techniques. ( 6763672 )
1982
14
[State of lymph node stroma in lympho- and reticulosarcoma]. ( 6994695 )
1980
15
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization. ( 370939 )
1978
16
Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (hematosarcomas or non-Hodgkin's lymphomas). ( 373918 )
1978
17
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. ( 373920 )
1978
18
Morphology of lymphoreticular tissues in mice with reticulosarcoma. ( 365565 )
1978
19
Modifications of macrophage chemotaxis in rats bearing the transplantable tumour reticulosarcoma 'IRE'. ( 335481 )
1977
20
Combination chemotherapy with adriamycine, VM 26, cyclophosphamide and prednisone in lymphosarcoma and reticulosarcoma stage III and IV. ( 326554 )
1977
21
Malignant lymphoma (reticulosarcoma) in bone. ( 334431 )
1977
22
Adult coeliac disease. A case with ulceration, dermatitis herpetiformis and reticulosarcoma. ( 766153 )
1976
23
Pathogenesis of ascites in a murine transplantable reticulosarcoma type A. ( 137595 )
1976
24
Hairy cell leukemia ('leukemic reticuleondotheliosis'), reticulosarcoma, and monocytic leukemia. Cytochemical and ultrastructural investigations. ( 808067 )
1975
25
Microglioma and/or reticulosarcoma of the nervous system. ( 51573 )
1975
26
Reticulosarcoma occurring during long-term hemodialysis. ( 1092500 )
1975
27
The effect of immunostimulation and chemotherapy on the growth of reticulosarcoma in mice. ( 4618487 )
1974
28
Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status). ( 4573872 )
1973
29
Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis. ( 4583173 )
1973
30
Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity. ( 4128515 )
1973
31
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression. ( 4577331 )
1973
32
Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. ( 4622181 )
1972
33
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma. ( 4925076 )
1971
34
Reticulosarcoma and amyloid development in BALB/c mice inoculated with syngeneic cells from young and old donors. ( 4941118 )
1971
35
Cytogenetic analysis in two cases of lymphoma. Comparison between lymphosarcoma and reticulosarcoma. ( 4910257 )
1970
36
Reticulosarcoma of the stomach. Report of 13 cases with follow-up results. ( 4931920 )
1970
37
Primary cerebral reticulosarcoma. ( 4913659 )
1970
38
Reticulosarcoma of the caecum. ( 5337477 )
1967
39
Electron microscopic study of tonsillar reticulosarcoma. II. Effect of radiation on tumor cells. ( 4886967 )
1967
40
Electron microscopic study of tonsillar reticulosarcoma. I. Features of malignancy in tumor cells. ( 4886966 )
1967
41
Reticulosarcoma of the eye treated with cyclophosphamide. ( 5336275 )
1966
42
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA. ( 14331625 )
1965
43
LYMPHOGRAPHY WITH RADIOACTIVE CONTRAST MEDIUM IN LYMPHOSARCOMA AND RETICULOSARCOMA. ( 14247471 )
1965
44
INTESTINAL RETICULOSARCOMA IN IDIOPATHIC STEATORRHOEA. ( 14273509 )
1964
45
ACQUIRED HYPOGAMMAGLOBULINAEMIA COMPLICATED BY RETICULOSARCOMA. ( 14098564 )
1963
46
Primary reticulosarcoma of the thyroid gland. ( 13742171 )
1961
47
Malignant tumours of the stomach arising from the lympho-reticular system. A report of 10 cases of lymphosarcoma and reticulosarcoma of the stomach. ( 14492653 )
1961
48
Case of Mesenteric Reticulosarcoma Associated with Gluten-sensitive Steatorrhoea. ( 20789212 )
1961
49
Trypan blue concentration and protein composition in sera of rats injected repeatedly with Trypan blue in relation to reticulosis and to reticulosarcoma. ( 13722875 )
1960
50
Reticulosarcoma complicating sarcoidosis. ( 13805580 )
1960

Variations for Reticulosarcoma

Expression for Reticulosarcoma

Search GEO for disease gene expression data for Reticulosarcoma.

Pathways for Reticulosarcoma

GO Terms for Reticulosarcoma

Biological processes related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.33 ALK CLU NPM1
2 adult behavior GO:0030534 9.32 ALK PAX5
3 positive regulation of receptor-mediated endocytosis GO:0048260 9.26 B2M CLU
4 regulation of apoptotic process GO:0042981 9.26 ALK BCL6 CLU TNFRSF8
5 regulation of cell proliferation GO:0042127 8.92 ALK BCL6 CCND3 TNFRSF8

Sources for Reticulosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....